Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Futaste Pharmaceutical is a prominent Chinese manufacturer specializing in functional sugar alcohols and sweeteners for the global healthcare and food industries. As a key subsidiary of the Futaste Group, the company produces high-quality pharmaceutical-grade xylitol, sorbitol, maltitol, and erythritol used as excipients and active ingredients. Their product portfolio also includes prebiotics such as xylo-oligosaccharides and L-arabinose, targeting metabolic and digestive health. Futaste maintains extensive manufacturing capabilities with international certifications, positioning itself as a leading global supplier for pharmaceutical formulations and health supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Futaste Pharmaceutical.